MIAMI, Sept. 18, 2012 /PRNewswire/ -- Fuisz LLC today announced its Cipher Watch patent has issued as US 8,264,910 (entitled "Cipher Watch").
Sixteen claims have issued, directed to a plurality of concentric rings with symbols and partial countervailing rotation to provide a cipher code.
Inventor Richard C. Fuisz, M.D. commented: "This successful allowance underscores the success of our novel product development efforts across a broad array of fields of interest. Our approach – to combine novel thinking with highly targeted research and development – works."
"I am particularly pleased with this effort because of my longtime interest in fine watches as well as my fervent believe that the values of privacy and reputation may be placed at risk by modern web technologies and systems. Not only is this a unique encryption device of substantial power but it allows for the sophisticated transfer between cipher text and plain text and back again and bestows an absolutely stunning look when applied to the watch dial. This in an era when the average expensive watch dial has become somewhat lacking and aesthetically boring. The adaption of this system is not that complex a departure from certain movements now on the market. The Face is stunning."
Joseph Fuisz, a co-inventor continued: "Commercially, we plan to license this patent family to one of the leading watch brands. We believe that there is a need for further innovation and product differentiation in fine mechanical watches."
Richard C. Fuisz, M.D. is a noted inventor in many disciplines: http://en.wikipedia.org/wiki/Richard_Fuisz.
Fuisz LLC is pursuing counterpart foreign patents in the important watchmaking markets, such as Switzerland and Germany and Italy.
About Fuisz LLC:
Fuisz LLC is a private technology company originated by the Fuiszes. The Fuiszes have made substantial contributions in pharmaceutical drug delivery including orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos
Pharma and MonoSol Rx, as well as independently developing extruded sheet technology, and have extensive experience working with large consumer products companies. The Fuiszes are also highly active in patents relating to e-commerce, novel database systems, electronic mail, and the medical diagnostic field. www.fuisz.com
SOURCE Fuisz LLC